These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27085543)

  • 21. A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation.
    Eroğlu S; Ozin B; Ozbiçer S; Müderrisoğlu H
    Turk Kardiyol Dern Ars; 2009 Jul; 37(5):337-40. PubMed ID: 19875908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful control of rapid heart rate in a patient with atrial fibrillation by continuous intravenous administration of landiolol hydrochloride].
    Konishi R; Maeda R; Endo I; Inoue N; Seo N
    Masui; 2003 May; 52(5):515-8. PubMed ID: 12795134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive effect of low-dose landiolol on postoperative atrial fibrillation study (PELTA study).
    Sasaki K; Kumagai K; Maeda K; Akiyama M; Ito K; Matsuo S; Katahira S; Suzuki T; Suzuki Y; Kaiho Y; Sugawara Y; Tsuji I; Saiki Y
    Gen Thorac Cardiovasc Surg; 2020 Nov; 68(11):1240-1251. PubMed ID: 32372277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results].
    Carbucicchio C; Lavarra F; Riva S; Fassini G; Della Bella P
    Cardiologia; 1995 Dec; 40(12):927-40. PubMed ID: 8901043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Landiolol infusion during general anesthesia does not prevent postoperative atrial fibrillation in patients undergoing lung resection.
    Aoyama H; Otsuka Y; Aoyama Y
    Gen Thorac Cardiovasc Surg; 2016 Dec; 64(12):735-741. PubMed ID: 27553581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What Determines the Response to Landiolol?
    Nitta D; Imamura T
    Circ J; 2019 Jun; 83(7):1617. PubMed ID: 31189754
    [No Abstract]   [Full Text] [Related]  

  • 28. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
    Kobayashi S; Murakami W; Myoren T; Tateishi H; Okuda S; Doi M; Nao T; Wada Y; Matsuzaki M; Yano M
    Cardiology; 2014; 127(2):105-13. PubMed ID: 24296610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What Determines the Response to Landiolol?　- Reply.
    Oka E; Iwasaki YK; Shimizu W
    Circ J; 2019 Jun; 83(7):1618-1619. PubMed ID: 31189755
    [No Abstract]   [Full Text] [Related]  

  • 30. Vanoxerine, a new drug for terminating atrial fibrillation and flutter.
    Matsumoto N; Khrestian CM; Ryu K; Lacerda AE; Brown AM; Waldo AL
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):311-9. PubMed ID: 19817929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of intra-operative low-dose infusion of landiolol hydrochloride on post-operative atrial fibrillation after off-pump coronary artery bypass grafting].
    Wakamatsu H; Takase S; Sato Y; Seto Y; Kurosawa H; Yokoyama H
    Kyobu Geka; 2010 Aug; 63(9):764-8. PubMed ID: 20715455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy.
    Brembilla-Perrot B; Schwartz J; Huttin O; Frikha Z; Sellal JM; Sadoul N; Blangy H; Olivier A; Louis S; Kaminsky P
    Pacing Clin Electrophysiol; 2014 Mar; 37(3):329-35. PubMed ID: 24117873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M
    Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.
    Sezai A; Nakai T; Hata M; Yoshitake I; Shiono M; Kunimoto S; Hirayama A
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1241-8. PubMed ID: 22858430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter].
    Maykov EB; Yuricheva YA; Mironov NY; Sokolov SF; Golitsyn SP; Rozenshtraukh LV; Chazov EI
    Ter Arkh; 2015; 87(1):38-48. PubMed ID: 25823268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial tachyarrhythmias after cardiac surgery: results of disopyramide therapy.
    Gavaghan TP; Feneley MP; Campbell TJ; Morgan JJ
    Aust N Z J Med; 1985 Feb; 15(1):27-32. PubMed ID: 3859260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of landiolol on heart rate control of atrial fibrillation in a patient with sick sinus syndrome under ventricular pacing].
    Satoh N; Kobayashi K; Kitoh T; Otagiri T
    Masui; 2006 Sep; 55(9):1161-3. PubMed ID: 16984016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
    J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a new class III drug niferidil in cardioversion of persistent atrial fibrillation and flutter.
    Maykov EB; Yuricheva YA; Mironov NY; Sokolov SF; Golitsyn SP; Rosenshtraukh LV; Chazov EI
    J Cardiovasc Pharmacol; 2014 Sep; 64(3):247-55. PubMed ID: 24785342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.